ARS Pharmaceuticals, Inc (SPRY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.36B
EV to revenue ratio (TTM)
2.46
EV to ebitda
-9.88
Financial Performance
Revenue (TTM)
$0.12B
Gross profit (TTM)
$0.06B
EBITDA
-$0.20B
Profitability
Operating margin (TTM)
-90.60%
Profit margin
-163.60%
Return on assets (TTM)
-39.50%
Return on equity (TTM)
-294.60%
Per Share Metrics
Revenue per share (TTM)
$1.23
EPS
-$2.01
Diluted EPS (TTM)
-$2.01
Book value
-$0.12
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
2.94
Price to book ratio (TTM)
20.82
Growth
Quarterly earnings growth (YoY)
16.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.16